Febuxostat Impurity 55 | CAS 1886961-39-2 - Request Quote
Febuxostat Impurity 55
| SZ CAT No: | SZ-F010091 |
| CAS No | 1886961-39-2 |
| Mol.F. | C14H12N2O3S |
| Mol.Wt. | 288.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Febuxostat Impurity 55 is chemically 2-(3-Cyano-4-ethoxyphenyl)-4-methylthiazole-5-carboxylic acid. Febuxostat Impurity 55 is supplied with detailed characterization data compliant with regulatory guideline. Febuxostat Impurity 55 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Febuxostat.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1886961-39-2
Purchase 1886961-39-2
Order 1886961-39-2
Enquire 1886961-39-2
price of 1886961-39-2
1886961-39-2 Supplier
1886961-39-2 Manufacturer
1886961-39-2 Exporter
buy high quality Febuxostat Impurity 55
Purchase Febuxostat Impurity 55
Febuxostat Impurity 55 suppliers
Febuxostat Impurity 55 manufacturers
Febuxostat Impurity 55 price
Order Febuxostat Impurity 55
Enquire Febuxostat Impurity 55
Febuxostat Impurity 55 cost
Febuxostat Impurity 55 Supplier
Febuxostat Impurity 55 Distributor
Febuxostat Impurity 55 for Method Validation
Febuxostat Reference Standard
Febuxostat Impurity 55 for ANDA Filing
Febuxostat Impurity 55 for Forced Degradation Studies
Febuxostat Impurity 55 Identification Standards
Febuxostat Impurity 55 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.